We are live on ! Find out more
PRPH

ProPhase Labs

Delisted

PRPH was delisted on the 2nd of January, 2026.

11 hedge funds and large institutions have $2.16M invested in ProPhase Labs in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

32% more capital invested

Capital invested by funds: $1.64M → $2.16M (+$529K)

0% more funds holding

Funds holding: 1111 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
11
Holders Change
Holders Change %
0%
% of All Funds
0.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

PRPH Hedge Fund Activity: Q3 2013 in Review

11 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q3 2013, worth a combined $2.16M — up 32% from $1.64M a quarter earlier.

Fund positioning in PRPH was balanced in Q3 2013: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.

The largest buyer was Bank of New York Mellon, adding an estimated $168K. The largest seller was Dimensional Fund Advisors, cutting an estimated $402.

  • 11 institutional investors held ProPhase Labs (PRPH) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $2.16M of ProPhase Labs stock for Q3 2013, up 32% quarter-over-quarter.
  • 1 fund opened new ProPhase Labs positions in Q3 2013 and 1 closed out, a net change of 0 holders.
  • The largest ProPhase Labs buyer in Q3 2013 was Bank of New York Mellon, an estimated $168K added.
  • The largest ProPhase Labs seller in Q3 2013 was Dimensional Fund Advisors, an estimated $402 sold.

Based on aggregated 13F filings for Q3 2013.